Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study

Journal of Neurosurgery

Volumn 84, Issue 3, 1996, Pages 449-458

  Negendank, William G ^a   Sauter, Rolf ^b   Brown, Truman R ^b   Evelhoch, Jeffrey L ^b   Falini, Andrea ^b   Gotsis, Efstathios D ^b   Heerschap, Arend ^b   Kamada, Kyousuke ^b   Lee, Benjamin C P ^b   Mengeot, Michel M ^b   Moser, Ewald ^b   Padavic Shaller, Kristin A ^b   Sanders, John A ^b   Spraggins, Thomas A ^b   Stillman, Arthur E ^b   Terwey, Burckhard ^b   Vogl, Thomas J ^b   Wicklow, Karsten ^b   Zimmerman, Robert A ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b NONE

Author keywords

brain neoplasm; glioma; lipids; magnetic resonance spectroscopy; metabolite

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; GLIOMA; GLUCOSE METABOLISM; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 13344259325     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.3.0449     Document Type: Article

References (62)

1. Alavi JB, Alavi A, Chawluk J, et al: Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62:1074-1078, 1988
2. Alger JR, Frank JA, Bizzi A, et al: Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177:633-641, 1990
3. 1H-MR spectra and spectroscopic imaging data. J Comput Assist Tomogr 17:191-199, 1993
4. Arnold DL, Shoubridge EA, Villemure JG, et al: Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading. NMR Biomed 3:184-189, 1990
5. Aronen HJ, Gazit IE, Louis DN, et al: Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51, 1994
6. 1H NMR spectrum of rat brain. Magn Reson Med 30:38-40, 1993
7. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333-348, 1987
8. Bruhn H, Frahm J, Gyngell ML, et al: Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 172:541-548, 1989
9. Burger PC, Vogel FS, Green SB, et al: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106-1111, 1985
10. Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas. A simple and reproducible method. Cancer 62: 2152-2165, 1988
11. 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 15:67-76, 1991
12. Frahm J, Bruhn H, Hänicke W, et al: Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. J Comput Assist Tomogr 15:915-922, 1991
13. Freitas I, Pontiggia P, Barni S, et al: Histochemical probes for the detection of hypoxic tumour cells. Anticancer Res 10: 613-622, 1990
14. Fulham MJ, Bizzi A, Dietz MJ, et al: Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185:675-686, 1992
15. 1H-CSI (chemical shift imaging) in brain tumors.] Nippon Igaku Hoshasen Gakkai Zasshi 51:836-838, 1991 (Jpn)
16. Gill SS, Thomas DGT, Van Bruggen N, et al: Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 14:497-504, 1990
17. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 30:341-344, 1985
18. Haase A, Frahm J, Matthaei D, et al: FLASH imaging. Rapid NMR imaging using low flip-angle pulses. J Magn Reson 67: 258-266, 1986
19. Hasso AN: Current status of enhanced magnetic resonance imagins in neuroradiology. Invest Radiol 28 (Suppl 1):S3-S20, 1993
20. Heesters MAAM, Kamman RL, Mooyaart EL, et al: Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy. J Neurooncol 17:27-35, 1993
21. 1H-spectroscopy of human intracranial tumors at 1.5 Tesla. Preliminary experience at a clinical installation. Acta Radiol 32:95-99, 1991
22. Herholz K, Heindel W, Luyten PR, et al: In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 31:319-327, 1992
23. Hölzer T, Herholz K, Jeske J, et al: FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 17:681-687, 1993
24. Husted CA, Duijn JH, Matson GB, et al: Molar quantitation of in vivo proton metabolites in human brain with 3D magnetic resonance spectroscopic imaging. Magn Reson Imaging 12: 661-667, 1994
25. Kim CK, Alavi JB, Alavi A, et al: New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 10:85-91, 1991
26. Kinoshita Y, Kajiwara H, Yokota A, et al: Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 35:606-613, 1994
27. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System, ed 2. Berlin: Springer-Verlag, 1993
28. Klose U: In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 14:26-30, 1990
29. Kreis R, Ernst T, Ross BD: Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson (B) 102:9-19, 1993
30. 1H MR spectroscopy. NMR Biomed 7:172-180, 1994
31. 1H MR spectroscopy of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 7:149-155, 1994
32. Kugel H, Heindel W, Ernestus RI, et al: Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 183:701-709, 1992
33. Lowry OH, Berger SJ, Chi MY, et al: Diversity of metabolic patterns in human brain tumors - I. High energy phosphate compounds and basic composition. J Neurochem 29:959-977, 1977
34. Majors A, Xue M, Ng TC, et al: Short echo time proton spectroscopy of human brain using a gradient head coil. Magn Reson Imaging 10:649-654, 1992
35. Michaelis T, Merboldt KD, Bruhn H, et al: Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187: 219-227, 1993
36. 1H NMR spectra of human brain in vivo. NMR Biomed 4:90-98, 1991
37. Moonen CTW, von Keinlin M, van Zijl PCM, et al: Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 2:201-208, 1989
38. Morantz RA: The management of the patient with low-grade cerebral astrocytomas, in Morantz RA, Walsh JW (eds): Brain Tumors. A Comprehensive Text New York: Marcel-Dekker, 1994, pp 387-415
39. 1H MRS in vivo in astrocyric tumors. Proc Soc Magn Reson Med 3:1296, 1994 (Abstract)
40. Negendank W, Zimmerman R, Gotsis E, et al: A cooperative group study of 1H MRS of primary brain tumors. Proc Soc Magn Reson Med 3:1521, 1993 (Abstract)
41. Nelson JS, Tsukada Y, Schoenfeld D, et al: Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 52:550-554, 1983
42. o field shifts following the application of pulsed gradients by phase correction in the time domain. J Magn Reson 69:151-155, 1986
43. Ott D, Hennig J, Ernst T: Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 186:745-752, 1993
44. Patronas NJ, Di Chiro G, Kufta C, et al: Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62:816-822, 1985
45. 1NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 24:123-136, 1992
46. Posse S, Schuknecht B, Smith ME, et al: Short echo time proton MR spectroscopic imaging. J Comput Assist Tomogr 17: 1-14, 1993
47. Preul MC, Caramanos Z, Collins JG, et al: Linear discriminant analysis based on proton MR spectroscopic imaging of human brain tumours improves pre-operative diagnosis. Proc Soc Magn Reson 2:125, 1994 (Abstract)
48. Radlbauer R, Langenberger KW, Moser E: Qualitätskontrolle für die lokalisierte In-vivo-Protonenspektroskopie an klinischen MR-Geräten. Roto Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 160:254-259, 1994
49. Remy C, Arús C, Ziegler A, et al: In vivo, ex vivo and in vitro one- and two-dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: assignment of resonances. J Neurochem 62:166-179, 1994
50. Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous System, ed 4. Baltimore: Williams & Wilkins, 1977
51. 1H NMR spectroscopy. J Neurochem 64:1655-1661, 1995
52. Salcman M (ed): Neurobiology of Brain Tumors. Baltimore. Williams & Wilkins, Vol 4, 1991
53. Sauter R: Cerebral single volume proton spectroscopy on healthy volunteers. A multicenter pilot study. Proc Soc Magn Reson Med 12:1531, 1993 (Abstract)
54. Scherer HJ: Cerebral astrocytomas and their derivatives. Am J Cancer 40:159-198, 1940
55. Schick F, Nägele T, Klose U, et al: Lactate quantification by means of PRESS spectroscopy - influence of refocusing pulses and timing scheme. Magn Reson Imaging 13:309-319, 1995
56. Schifter T, Hoffman JM, Hanson MW, et al: Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 17:509-516, 1993
57. 1H NMR spectroscopic imaging. Magn Reson Med 13: 62-76, 1990
58. Sutton LN, Wang Z, Gusnard D, et al: Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 31:195-202, 1992
59. 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro. J Neurosurg 81:443-448, 1994
60. Tzika AA, Vigneron DB, Ball WS Jr, et al: Localized proton MR spectroscopy of the brain in children. J Magn Reson Imaging 3:719-729, 1993
61. 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 18:705-713, 1994
62. Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71: 487-493, 1989